NASDAQ: CTY
City Therapeutics Inc Earnings Dates, Reports, Calls

City Therapeutics earnings were N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest CTY earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CTY reported annual earnings of -$58.5M, with 110.2% growth.

CTY earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

CTY Return on Equity

Insufficient data to display

CTY Return on Assets

Insufficient data to display

Be the first to know when CTY announces earnings.

CTY Return on Capital Employed

Current Company
0%
Current Industry
-7.4%

CTY vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AARD-$69.51M-$69.89MN/A-$3.21
ACET-$89.96M-$98.97MN/A-$10.46
ABVC-$6.46M-$7.11MN/A-$0.29
ABVX-$285.22M-$460.11MN/A-$5.96
TRXBN/AN/AN/AN/A

City Therapeutics Earnings Reports & History FAQ

What was CTY's earnings growth in the past year?

As of City Therapeutics's earnings date in Q4 2026, City Therapeutics's earnings has grown year over year. CTY earnings in the past year totalled N/A.

If you're new to stock investing, here's how to buy City Therapeutics stock.

Is City Therapeutics profitable or losing money?

As of the last City Therapeutics earnings report, City Therapeutics is currently losing money. City Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was N/A, a N/A decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.